Pharmacodynamics During Transition Between Platelet P2Y12 Inhibiting Therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacodynamics During Transition Between Platelet P2Y12 Inhibiting Therapies

Published:2019-10 Issue:4 Volume:8 Page:321-340
ISSN:2211-7458
Container-title:Interventional Cardiology Clinics
language:en
Short-container-title:Interventional Cardiology Clinics

Author:

Capranzano Piera,Francaviglia Bruno,Angiolillo Dominick J.

Funder

Amgen

AstraZeneca

Bayer

Biosensors

CeloNova

CSL Behring

Daiichi-Sankyo

Eisai

Eli Lilly

Gilead

Idorsia

Janssen

Matsutani Chemical Industry Co.

Merck

Novartis

Osprey Medical

Renal Guard Solutions

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference68 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

2. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines;Levine;J Am Coll Cardiol,2016

3. Novel antiplatelet agents in acute coronary syndrome;Franchi;Nat Rev Cardiol,2015

4. Switching between P2Y12 inhibitors: rationale, methods, and expected consequences;Capranzano;Vascul Pharmacol,2019

5. Switching P2Y12 receptor inhibiting therapies;Rollini;Interv Cardiol Clin,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basics of Antiplatelet and Anticoagulant Therapy for Cardiovascular Disease;Interventional Cardiology;2022-05-06

2. Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor;Thrombosis and Haemostasis;2021-01-07

3. Management of antithrombotic therapy in patients with bleeding after coronary angioplasty;G ITAL CARDIOL;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3